Moderna CEO Stéphane Bancel Talks Vaccine Collaboration With Merck

Stéphane Bancel, Moderna CEO, said in an interview with Bloomberg's Romaine Bostick, that he believes the personalized mRNA cancer vaccine his company is developing with Merck & Co. will work in a variety of tumors, directly addressing a key issue shrouding the company’s future. 

See omnystudio.com/listener for privacy information.